Monopar Therapeutics
MNPR
MNPR
74 hedge funds and large institutions have $361M invested in Monopar Therapeutics in 2025 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 33 increasing their positions, 9 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
2% more capital invested
Capital invested by funds: $354M → $361M (+$6.5M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
74
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$17.3M | |
| 2 | +$13.9M | |
| 3 | +$12.7M | |
| 4 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$8.64M |
| 5 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
+$8.49M |
Top Sellers
| 1 | -$6.49M | |
| 2 | -$5.26M | |
| 3 | -$2.53M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$1.61M |
| 5 |
TCM
TCG Crossover Management
Palo Alto,
California
|
-$906K |
